Some large Indian brokerage firms have asked clients to furnish higher margins against trades this week to limit the risk of default ahead ...

Hindustan Zinc surged 20%, followed by Vedanta which gained 7.04%. Jindal Steel and Power and Hindalco moved up over 4%, while Tata Steel, ...

Prabhudas Liladher has upgraded VIP Industries to 'Buy' from 'Hold' rating for a target of Rs 603, which has been revised up from earlier R...

Investment will help the airline to induct fresh capacity and reduce liabilities, thereby reducing cost of capital, said SpiceJet promoter ...

When the liquidity and interest rates are slow, it's the midcaps and smallcaps that start performing.

Shankar Sharma says post-state election market rally is a sign of bulls making a comeback.

"The price target for Infy on a 12-month basis is Rs 1430. We have given it 18 times FY20 earnings."

If anything goes wrong drastically, like what Trump said, there needs to be a lot of clarity as it could be very negative for large Indian ...

My problem with a company like Granules is that I really cannot bet on a company which is betting highly on a highly commoditised product, ...

This government understands the infra space and is ensuring that the orders can really be completed

"Midcaps in logistics, infra, auto, chemicals and and the market cap up to Rs 12,000 crore to Rs 14,000 crore have been showcased"

BSE Healthcare index fell by 2% at 14479 compared to its previous close of 14888 on Monday, the Sensex closed at 26781, down by 1.97%.

Shares of Infosys Technologies shed 2% to Rs 2,919 on Monday ahead of the company’s first quarter results on Tuesday.

Axis Bank continued its winning streak, reporting a 36% net profit growth on a year-on-year basis in the December 2010 quarter.

Prabhudas Lilladher has upgraded its rating on Deepak Fertilisers & Petrochemicals Corp to 'accumulate' from reduce, citing improved feedst...

A few local brokerage houses have started hiring selectively to strengthen their research and sales team.

The Indian pharma firm’s open offer to Taro shareholders is on and Taro is currently trading $7.75 below the price offered by Sun Pharma. T...